Details
Stereochemistry | ACHIRAL |
Molecular Formula | Pb.S |
Molecular Weight | 239.3 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[S--].[PbH2++]
InChI
InChIKey=DDCACOMLHWHRLN-UHFFFAOYSA-N
InChI=1S/Pb.S.2H/q+2;-2;;
Molecular Formula | Pb |
Molecular Weight | 207.2 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | HS |
Molecular Weight | 33.073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://nj.gov/health/eoh/rtkweb/documents/fs/1107.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/27486358https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/20340530 | https://www.ncbi.nlm.nih.gov/pubmed/18935555https://www.ncbi.nlm.nih.gov/pubmed/2535340FRITZ BISCHOFF, L. C. MAXWELL, RICHARD D. EVANS, and FRANKLIN R. NUZUM. Journal of Pharmacology and Experimental Therapeutics September 1928, 34 (1) 85-109, retrived from http://jpet.aspetjournals.org/content/34/1/85 | https://www.ncbi.nlm.nih.gov/pubmed/14038324Curator's Comment: description was created based on several sources, including
https://ntp.niehs.nih.gov/ntp/newhomeroc/roc11/lead-public_508.pdf
Sources: http://nj.gov/health/eoh/rtkweb/documents/fs/1107.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/27486358https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/20340530 | https://www.ncbi.nlm.nih.gov/pubmed/18935555https://www.ncbi.nlm.nih.gov/pubmed/2535340FRITZ BISCHOFF, L. C. MAXWELL, RICHARD D. EVANS, and FRANKLIN R. NUZUM. Journal of Pharmacology and Experimental Therapeutics September 1928, 34 (1) 85-109, retrived from http://jpet.aspetjournals.org/content/34/1/85 | https://www.ncbi.nlm.nih.gov/pubmed/14038324
Curator's Comment: description was created based on several sources, including
https://ntp.niehs.nih.gov/ntp/newhomeroc/roc11/lead-public_508.pdf
There is no information about biological and pharmacological application of lead sulfide. But is known, that sulfide of the lead is insoluble and a stable compound in the pH of blood and so one of the less toxic forms of lead. Chronic exposure may lead to the respiratory system toxicity, irritation of skin.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The effect of topical applications of lead fluoride on dental caries. | 1947 Dec |
|
The effect of topically applied fluorides on dental caries experience; report of findings with two, four and six applications of sodium fluoride and of lead fluoride. | 1947 Oct 10 |
|
[Contribution to the study on allergy among workers exposed to lead oxide and lead sulfide]. | 1961 Jul-Dec |
|
Microbial uptake of lead. | 1972 Jun 23 |
|
Interaction of lead and bacterial lipids. | 1975 May |
|
Subacute effects of lead-oxide fumes in demolition workers. | 1977 Jan 8 |
|
Abiotic factors affecting the toxicity of lead to fungi. | 1979 Sep |
|
Interconnection of activation volumes and activation enthalpies in cubic lead fluoride doped with alkali-metal cations. | 1985 Jun 15 |
|
Lead oxide emissions--a case history. | 1986 |
|
Mutagenic effects of lead (II) bromide. | 1989 Dec |
|
[The late effects of exposure to lead fluoride]. | 1992 Mar |
|
Structural Chemistry of Poly(ethylene glycol) Complexes of Lead(II) Nitrate and Lead(II) Bromide. | 1996 Nov 20 |
|
[Lead in the blood and protoporphyrin levels in erythrocytes in glass workers exposed to lead]. | 1997 Dec |
|
Maternal low-level lead exposure reduces the expression of PSA-NCAM and the activity of sialyltransferase in the hippocampi of neonatal rat pups. | 2008 Jul |
|
The oxidative damage and inflammatory response induced by lead sulfide nanoparticles in rat lung. | 2013 Oct |
|
Autophagy plays a protective role in cell death of osteoblasts exposure to lead chloride. | 2015 Dec 3 |
|
Probit analysis of comparative assays on toxicities of lead chloride and lead acetate to in vitro cultured human umbilical cord blood lymphocytes. | 2015 Mar |
|
Rat Testis Damage Caused by Lead Sulfide Nanoparticles After Oral Exposure. | 2016 Mar |
|
Highly luminescent nanoscale quasi-2D layered lead bromide perovskites with tunable emissions. | 2016 Mar 11 |
Sample Use Guides
In Vivo Use Guide
Sources: https://m.cameochemicals.noaa.gov/chris/LID.pdf
Toxicity by Ingestion: Grade 2; LD50 = 0.5-5 g/kg.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 16 22:58:33 UTC 2022
by
admin
on
Fri Dec 16 22:58:33 UTC 2022
|
Record UNII |
2425D15SYM
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
215-246-6
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY | |||
|
2425D15SYM
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY | |||
|
C018391
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY | |||
|
1314-87-0
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY | |||
|
DTXSID0025498
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY | |||
|
M6746
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY | Merck Index | ||
|
LEAD(II) SULFIDE
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY | |||
|
2425D15SYM
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY | |||
|
639
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY | |||
|
1549104
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY | RxNorm | ||
|
9794739
Created by
admin on Fri Dec 16 22:58:33 UTC 2022 , Edited by admin on Fri Dec 16 22:58:33 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |